Multiple Myeloma

• Daratumumab 1800 / Bortezomib 1.5 / Cyclophosphamide 300 / Dexamethasone (20/20), Multiple Myeloma, Cycle 1-2 PID 1941 V1.0 (2025-08-22)
  V1.0: Cato test done V0.1: Dosing and durations according to primary literature, dose distribution of Dexamethasone according to the professional information

Protocols in Revision

Multiple Myeloma

• Bortezomib 1.3 / Lenalidomide 25 / Dexamethasone 20 / Isatuximab 10, multiple myeloma, induction, IB, cycle 1 PID 41 V1.2
• Bortezomib 1.3 / Lenalidomide 25 / Dexamethasone 20 / Isatuximab 10, multiple myeloma, induction, IB, cycle 2-3 PID 42 V1.2